EXAS vs MAC · rev $2.76B vs rev $918.2M
EXACT Sciences Corporation (EXAS) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
EXAS currently screens at market cap $20.03B. MAC currently screens at market cap $4.41B.
Not investment advice. Open the EXAS and MAC stock pages for the full models.
Not investment advice.